Can a phone app help prevent heart attacks? new study aims to find out

NCT ID NCT06919302

First seen Jan 09, 2026

Summary

This study tests whether a digital heart health program (a web app, online classes, and special foods) added to usual care can lower cholesterol and reduce heart attacks in people with heart disease or risk factors. About 1,100 participants will be randomly assigned to the program or usual care alone and followed for up to 7 years. The goal is to see if technology can help doctors provide better nutrition support and improve heart health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • C. David Naylor Building

    RECRUITING

    Toronto, Ontario, M5S1A8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Digital heart health program (web app, online sessions, and key foods)

What this could lead to

If it works, this could provide a practical, scalable way for doctors to help patients improve heart health through diet and lifestyle changes.

What could go wrong

This is a large but early-stage behavioral study; results depend on participants sticking with the program, and it may not show clear benefits over standard care alone.

Conditions

The condition(s) this trial relates to.

atherosclerotic cardiovascular disease cardiovascular disorder Dyslipidemias inherited lipid metabolism disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.